# FDA 483 - Crescent Marketing, Inc. dba Crescent Mfg - August 28, 2025

Source: https://www.keypedia.com/records/483/crescent-marketing-inc-dba-crescent-mfg/e5a0384d-0fe1-4402-b9e8-27ce2ac04394

> FDA 483 for Crescent Marketing, Inc. dba Crescent Mfg on August 28, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Crescent Marketing, Inc. dba Crescent Mfg
- Inspection Date: 2025-08-28
- Product Type: drugs
- Office Name: New York District Office
- Summary: Crescent Marketing Inc., a manufacturer of OTC products in North Collins, NY, was cited for significant cGMP deficiencies during an FDA inspection. The firm lacks a designated quality control unit, has inadequate data integrity controls for analytical data, and fails to properly sanitize equipment or validate cleaning procedures to prevent cross-contamination. Additionally, employees, including key quality and manufacturing personnel, lack adequate and up-to-date GMP training.

## Related Officers

- [Jordan S. Burkdoll](https://www.keypedia.com/people/jordan-s-burkdoll/3e68ac2c-b35d-41d2-8451-309a18dda38c)
- [Lauren H. Augustyniak](https://www.keypedia.com/people/lauren-h-augustyniak/bde81fac-921f-494b-969b-38770fceda7e)

Company: https://www.keypedia.com/companies/crescent-marketing-inc-dba-crescent-mfg/fccc8bfe-ecf0-4f8f-bccb-25b6d7970943

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d